- Published on
Emergency and Acute Medicine – Pediatric Asthma
Clinical Overview
Pediatric asthma is a common inflammatory airway disease affecting about 2.7 million children (<18 years) in the united states and accounts for roughly 850,000 emergency department visits annually. viral-driven airway inflammation commonly triggers bronchoconstriction, which is amplified by hyperreactivity inflammatory mediators. resulting airflow obstruction increases resistance causes gas trapping, driven mucosal edema, bronchospasm, mucus plugging. infants are particularly prone to respiratory failure because of higher peripheral resistance, reduced elastic recoil with earlier closure, an unstable rib cage, a mechanically disadvantaged diaphragm. risk influenced family history allergy early injury or vulnerability such as bronchopulmonary dysplasia, prior pneumonia, intubation, croup, reflux, passive smoke exposure; reactions foods medications other allergic conditions also support atopic predisposition. environmental exposures including pets, cigarette smoke, carpets, dust can precipitate worsen symptoms.< />pan>
Common Causes And Triggers
Exacerbations are often precipitated by infection, most commonly viral but sometimes bacterial. Environmental allergens and irritants are frequent contributors, including pollens, grasses, mold, house dust mites, and animal dander, as well as airborne chemicals such as chlorine or ammonia and food-related additives. Smoke, pollutants, gases, and aerosols may aggravate bronchospasm. Exercise, cold weather, and emotional stressors (including phobias) can provoke symptoms. Medication-related triggers include beta-blockers, aspirin, and NSAIDs.
Clinical Features
Children may present with fatigue or somnolence, diaphoresis, agitation, hypoxia or cyanosis, tachycardia, dehydration, and pulsus paradoxus. Respiratory findings include wheezing, rales, or rhonchi; acute or chronic cough; tachypnea; chest tightness; dyspnea with a prolonged expiratory phase; retractions with accessory muscle use and nasal flaring; and signs of hyperinflation. Many have a history of recurrent episodes and chronic activity restriction. Potential complications include recurrent pneumonia or bronchitis, atelectasis, pneumothorax or pneumomediastinum, and in severe cases respiratory distress, respiratory failure, or death.
History And Examination
History should focus on precipitating events and known triggers, symptom duration and progression, comorbid illness, and prior disease severity markers including previous hospitalizations, prior intubations or ICU care, and current regular or intermittent medications. Examination should include vital signs with pulse oximetry and a focused respiratory assessment. Wheeze intensity can be misleading; absent wheezing may indicate critically reduced airflow with diminished breath sounds. Look for hypoxia through skin and nail bed color changes and assess for fatigue or impending failure by noting accessory muscle use or retractions, lethargy, confusion, somnolence, or exhaustion.
Essential Evaluation
Diagnosis is clinical and relies on history and physical examination. Ventilation is assessed by observing work of breathing (retractions and accessory muscle use) and by auscultation for air exchange. Clinical response to bronchodilators should be tracked in the current episode and interpreted in the context of prior episodes. Alternative diagnoses must be considered and excluded. Initial pulse oximetry is important; an oxygen saturation below 91% at sea level correlates with more significant illness and is associated with admission risk, relapse, and a more prolonged course. Peak flow measurement can help in cooperative children, typically those older than five years; values below 50–70% of predicted suggest moderate to severe obstruction, 70–90% aligns with mild to moderate disease, and above 90% is considered normal.
Tests And Imaging
Arterial blood gas testing is not routine and is not mandatory; it can supplement oximetry for oxygenation assessment and support clinical judgment about ventilation when needed. CBC may be obtained as a nonspecific marker when infection is a concern. Theophylline levels are relevant only if a child is taking theophylline, though this therapy is not recommended. Chest radiography is considered selectively to evaluate for infiltrates, bronchial wall thickening, or hyperexpansion, and is especially considered in infants under one year to help exclude foreign body aspiration or atelectasis, in a first episode of significant wheezing to help assess chronicity and alternative diagnoses, in worsening distress or poor response to therapy, in respiratory distress or failure, and in shortness of breath without wheeze.
Differential Diagnosis
Infectious or inflammatory mimics include bronchiolitis, which can be difficult to distinguish clinically aside from age and history, and pneumonia of viral, bacterial, chemical, or hypersensitivity origin. Aspiration, deep neck or mediastinal abscesses or masses, and anaphylaxis must be considered. Structural and anatomic problems include pneumothorax and foreign body aspiration. Vascular causes include tracheal compression from vascular anomalies, pulmonary embolism, and heart failure. Congenital and chronic disorders include cystic fibrosis, tracheoesophageal fistula, bronchogenic cysts, and congenital heart disease. Other considerations include intoxication or medication effects, metabolic acidosis, neoplasm, vocal cord dysfunction, pulmonary edema (cardiogenic or noncardiogenic), and gastroesophageal reflux.
Prehospital Care
Field care emphasizes oxygen and continuous oxygen saturation monitoring, nebulized beta-agonist therapy such as albuterol, and rapid transport with clear communication to the receiving emergency team. Intubation is required for respiratory failure or profound fatigue. Intravenous fluids should be given when dehydration is evident.
Initial Stabilization In The ED
The immediate goal is to maintain oxygen saturation above 90–95% while initiating inhaled beta-agonist therapy. Intubation is indicated for respiratory failure. If dehydration is present, administer a 20 mL/kg bolus of 0.9% normal saline.
Emergency Department Management
Evaluate for impending respiratory failure, focusing on cyanosis, severe anxiety or irritability, lethargy or somnolence, fatigue, persistent tachypnea, markedly reduced air entry, and poor ventilation. Oxygen should be titrated to maintain saturations above 95% at sea level. Albuterol is the primary bronchodilator and may be given frequently or continuously in severe exacerbations. Levalbuterol may be associated with fewer side effects and may allow less frequent dosing in some children. Ipratropium bromide can be added as an adjunct, with the best benefit seen when combined with the first three beta-agonist treatments in moderate to severe presentations. Systemic steroids are recommended, using oral administration for moderate exacerbations when oral intake is possible and intravenous dosing for severe illness or inability to tolerate oral medications; a single dose of dexamethasone may be comparable to more traditional steroid courses. Subcutaneous epinephrine or terbutaline is reserved for severe or refractory cases and is used infrequently. Magnesium sulfate may help in severe asthma that persists despite standard therapy. If intubation is required, ketamine is a useful induction agent. A 20 mL/kg normal saline bolus remains appropriate if dehydration is present. Heliox may be considered, although evidence is mixed and results remain inconclusive.
Medication Regimens
Albuterol may be given by nebulizer at 0.15 mg/kg per dose up to 5 mg per dose every 15–30 minutes as needed, or via MDI with spacer at 90 micrograms per puff using two puffs every 5–10 minutes to a maximum of 10 puffs. Dexamethasone can be given at 0.3 mg/kg per dose up to 16 mg. Epinephrine 1:1,000 may be administered subcutaneously at 0.01 mg/kg up to 0.35 mL per dose every 20 minutes for up to three doses. Ipratropium bromide nebulizer dosing is 250–500 micrograms per dose every six hours. Ketamine for intubation is typically 1–2 mg/kg IV as an induction agent. Levalbuterol is available in 0.63 mg and 1.25 mg vials for nebulization, typically dosed every 6–8 hours. Magnesium sulfate is dosed at 25 mg/kg IV over 20 minutes, with a maximum of about 1.2–2 g per dose. Methylprednisolone is given at 1–2 mg/kg per dose IV every six hours with a maximum of 125 mg per dose. Prednisolone is dosed 1–2 mg/kg per dose orally every 12 hours, and prednisone 1–2 mg/kg per dose orally every 6–12 hours with a maximum of 80 mg per dose. Terbutaline may be given subcutaneously as 0.01 mL/kg of 0.01% solution every 15–20 minutes up to 0.25 mL per dose, with repeated dosing per protocol. First-line therapy is albuterol plus systemic steroids with ipratropium as an adjunct, while second-line escalation includes epinephrine or terbutaline and magnesium sulfate.
Disposition And Observation
Admission decisions should be individualized using symptoms, examination, and objective measurements. Hospital admission is generally indicated for persistent wheezing, ongoing tachypnea, continued retractions or accessory muscle use, room-air saturation below 93% at sea level, peak flow below 50–70% predicted, inability to tolerate oral fluids or medications, a return ED visit within the prior 24 hours, and significant comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, or neuromuscular disease, as well as concomitant pneumonia or severe viral infection. ICU-level care is indicated for severe respiratory distress, saturation below 90% or PaO2 below 60 mm Hg while receiving 40% oxygen, PaCO2 above 40 mm Hg, or significant complications such as pneumothorax or dysrhythmia. Discharge is appropriate only after a clearly good response to treatment and after observing the child for 60 minutes after the last therapy. Discharge targets include peak flow above 70% predicted for age and height, room-air saturation above 93% at sea level, normal respiratory rate, no retractions, clear lungs or only minimal wheeze, minimal or no dyspnea, and reliable follow-up and adherence. Discharge planning should include reducing exposure to smoke and allergens, continuing an intensive beta-agonist regimen for 3–5 days, and prescribing a short 3–5 day steroid course at 2 mg/kg/day for those with at least moderate symptoms. Children with moderate or severe exacerbations should have arrangements for inhaled corticosteroids over the next 1–2 months, such as fluticasone, budesonide, or beclomethasone. Follow-up should be arranged within 24–72 hours, with clear return precautions for shortness of breath that does not respond to the home regimen. Longer-term controller planning should be considered for children with recurrent attacks, persistent symptoms, or activity limitation.
Follow-Up Planning
Ongoing care is typically coordinated through the primary care clinician and often includes inhaled steroid maintenance therapy, instruction in rescue treatment, and education to support early recognition and appropriate escalation during future exacerbations.
Clinical Lessons And Safety Points
Rapid initiation of therapy with frequent reassessment is crucial to detect deterioration early. When admitting children, ensure that beta-agonist treatments continue without interruption.
Clinical Overview
Pediatric asthma is a common inflammatory airway disease affecting about 2.7 million children (<18 years) in the united states and accounts for roughly 850,000 emergency department visits annually. viral-driven airway inflammation commonly triggers bronchoconstriction, which is amplified by hyperreactivity inflammatory mediators. resulting airflow obstruction increases resistance causes gas trapping, driven mucosal edema, bronchospasm, mucus plugging. infants are particularly prone to respiratory failure because of higher peripheral resistance, reduced elastic recoil with earlier closure, an unstable rib cage, a mechanically disadvantaged diaphragm. risk influenced family history allergy early injury or vulnerability such as bronchopulmonary dysplasia, prior pneumonia, intubation, croup, reflux, passive smoke exposure; reactions foods medications other allergic conditions also support atopic predisposition. environmental exposures including pets, cigarette smoke, carpets, dust can precipitate worsen symptoms.< />pan>
Common Causes And Triggers
Exacerbations are often precipitated by infection, most commonly viral but sometimes bacterial. Environmental allergens and irritants are frequent contributors, including pollens, grasses, mold, house dust mites, and animal dander, as well as airborne chemicals such as chlorine or ammonia and food-related additives. Smoke, pollutants, gases, and aerosols may aggravate bronchospasm. Exercise, cold weather, and emotional stressors (including phobias) can provoke symptoms. Medication-related triggers include beta-blockers, aspirin, and NSAIDs.
Clinical Features
Children may present with fatigue or somnolence, diaphoresis, agitation, hypoxia or cyanosis, tachycardia, dehydration, and pulsus paradoxus. Respiratory findings include wheezing, rales, or rhonchi; acute or chronic cough; tachypnea; chest tightness; dyspnea with a prolonged expiratory phase; retractions with accessory muscle use and nasal flaring; and signs of hyperinflation. Many have a history of recurrent episodes and chronic activity restriction. Potential complications include recurrent pneumonia or bronchitis, atelectasis, pneumothorax or pneumomediastinum, and in severe cases respiratory distress, respiratory failure, or death.
History And Examination
History should focus on precipitating events and known triggers, symptom duration and progression, comorbid illness, and prior disease severity markers including previous hospitalizations, prior intubations or ICU care, and current regular or intermittent medications. Examination should include vital signs with pulse oximetry and a focused respiratory assessment. Wheeze intensity can be misleading; absent wheezing may indicate critically reduced airflow with diminished breath sounds. Look for hypoxia through skin and nail bed color changes and assess for fatigue or impending failure by noting accessory muscle use or retractions, lethargy, confusion, somnolence, or exhaustion.
Essential Evaluation
Diagnosis is clinical and relies on history and physical examination. Ventilation is assessed by observing work of breathing (retractions and accessory muscle use) and by auscultation for air exchange. Clinical response to bronchodilators should be tracked in the current episode and interpreted in the context of prior episodes. Alternative diagnoses must be considered and excluded. Initial pulse oximetry is important; an oxygen saturation below 91% at sea level correlates with more significant illness and is associated with admission risk, relapse, and a more prolonged course. Peak flow measurement can help in cooperative children, typically those older than five years; values below 50–70% of predicted suggest moderate to severe obstruction, 70–90% aligns with mild to moderate disease, and above 90% is considered normal.
Tests And Imaging
Arterial blood gas testing is not routine and is not mandatory; it can supplement oximetry for oxygenation assessment and support clinical judgment about ventilation when needed. CBC may be obtained as a nonspecific marker when infection is a concern. Theophylline levels are relevant only if a child is taking theophylline, though this therapy is not recommended. Chest radiography is considered selectively to evaluate for infiltrates, bronchial wall thickening, or hyperexpansion, and is especially considered in infants under one year to help exclude foreign body aspiration or atelectasis, in a first episode of significant wheezing to help assess chronicity and alternative diagnoses, in worsening distress or poor response to therapy, in respiratory distress or failure, and in shortness of breath without wheeze.
Differential Diagnosis
Infectious or inflammatory mimics include bronchiolitis, which can be difficult to distinguish clinically aside from age and history, and pneumonia of viral, bacterial, chemical, or hypersensitivity origin. Aspiration, deep neck or mediastinal abscesses or masses, and anaphylaxis must be considered. Structural and anatomic problems include pneumothorax and foreign body aspiration. Vascular causes include tracheal compression from vascular anomalies, pulmonary embolism, and heart failure. Congenital and chronic disorders include cystic fibrosis, tracheoesophageal fistula, bronchogenic cysts, and congenital heart disease. Other considerations include intoxication or medication effects, metabolic acidosis, neoplasm, vocal cord dysfunction, pulmonary edema (cardiogenic or noncardiogenic), and gastroesophageal reflux.
Prehospital Care
Field care emphasizes oxygen and continuous oxygen saturation monitoring, nebulized beta-agonist therapy such as albuterol, and rapid transport with clear communication to the receiving emergency team. Intubation is required for respiratory failure or profound fatigue. Intravenous fluids should be given when dehydration is evident.
Initial Stabilization In The ED
The immediate goal is to maintain oxygen saturation above 90–95% while initiating inhaled beta-agonist therapy. Intubation is indicated for respiratory failure. If dehydration is present, administer a 20 mL/kg bolus of 0.9% normal saline.
Emergency Department Management
Evaluate for impending respiratory failure, focusing on cyanosis, severe anxiety or irritability, lethargy or somnolence, fatigue, persistent tachypnea, markedly reduced air entry, and poor ventilation. Oxygen should be titrated to maintain saturations above 95% at sea level. Albuterol is the primary bronchodilator and may be given frequently or continuously in severe exacerbations. Levalbuterol may be associated with fewer side effects and may allow less frequent dosing in some children. Ipratropium bromide can be added as an adjunct, with the best benefit seen when combined with the first three beta-agonist treatments in moderate to severe presentations. Systemic steroids are recommended, using oral administration for moderate exacerbations when oral intake is possible and intravenous dosing for severe illness or inability to tolerate oral medications; a single dose of dexamethasone may be comparable to more traditional steroid courses. Subcutaneous epinephrine or terbutaline is reserved for severe or refractory cases and is used infrequently. Magnesium sulfate may help in severe asthma that persists despite standard therapy. If intubation is required, ketamine is a useful induction agent. A 20 mL/kg normal saline bolus remains appropriate if dehydration is present. Heliox may be considered, although evidence is mixed and results remain inconclusive.
Medication Regimens
Albuterol may be given by nebulizer at 0.15 mg/kg per dose up to 5 mg per dose every 15–30 minutes as needed, or via MDI with spacer at 90 micrograms per puff using two puffs every 5–10 minutes to a maximum of 10 puffs. Dexamethasone can be given at 0.3 mg/kg per dose up to 16 mg. Epinephrine 1:1,000 may be administered subcutaneously at 0.01 mg/kg up to 0.35 mL per dose every 20 minutes for up to three doses. Ipratropium bromide nebulizer dosing is 250–500 micrograms per dose every six hours. Ketamine for intubation is typically 1–2 mg/kg IV as an induction agent. Levalbuterol is available in 0.63 mg and 1.25 mg vials for nebulization, typically dosed every 6–8 hours. Magnesium sulfate is dosed at 25 mg/kg IV over 20 minutes, with a maximum of about 1.2–2 g per dose. Methylprednisolone is given at 1–2 mg/kg per dose IV every six hours with a maximum of 125 mg per dose. Prednisolone is dosed 1–2 mg/kg per dose orally every 12 hours, and prednisone 1–2 mg/kg per dose orally every 6–12 hours with a maximum of 80 mg per dose. Terbutaline may be given subcutaneously as 0.01 mL/kg of 0.01% solution every 15–20 minutes up to 0.25 mL per dose, with repeated dosing per protocol. First-line therapy is albuterol plus systemic steroids with ipratropium as an adjunct, while second-line escalation includes epinephrine or terbutaline and magnesium sulfate.
Disposition And Observation
Admission decisions should be individualized using symptoms, examination, and objective measurements. Hospital admission is generally indicated for persistent wheezing, ongoing tachypnea, continued retractions or accessory muscle use, room-air saturation below 93% at sea level, peak flow below 50–70% predicted, inability to tolerate oral fluids or medications, a return ED visit within the prior 24 hours, and significant comorbidities such as congenital heart disease, bronchopulmonary dysplasia, cystic fibrosis, or neuromuscular disease, as well as concomitant pneumonia or severe viral infection. ICU-level care is indicated for severe respiratory distress, saturation below 90% or PaO2 below 60 mm Hg while receiving 40% oxygen, PaCO2 above 40 mm Hg, or significant complications such as pneumothorax or dysrhythmia. Discharge is appropriate only after a clearly good response to treatment and after observing the child for 60 minutes after the last therapy. Discharge targets include peak flow above 70% predicted for age and height, room-air saturation above 93% at sea level, normal respiratory rate, no retractions, clear lungs or only minimal wheeze, minimal or no dyspnea, and reliable follow-up and adherence. Discharge planning should include reducing exposure to smoke and allergens, continuing an intensive beta-agonist regimen for 3–5 days, and prescribing a short 3–5 day steroid course at 2 mg/kg/day for those with at least moderate symptoms. Children with moderate or severe exacerbations should have arrangements for inhaled corticosteroids over the next 1–2 months, such as fluticasone, budesonide, or beclomethasone. Follow-up should be arranged within 24–72 hours, with clear return precautions for shortness of breath that does not respond to the home regimen. Longer-term controller planning should be considered for children with recurrent attacks, persistent symptoms, or activity limitation.
Follow-Up Planning
Ongoing care is typically coordinated through the primary care clinician and often includes inhaled steroid maintenance therapy, instruction in rescue treatment, and education to support early recognition and appropriate escalation during future exacerbations.
Clinical Lessons And Safety Points
Rapid initiation of therapy with frequent reassessment is crucial to detect deterioration early. When admitting children, ensure that beta-agonist treatments continue without interruption.
- Published on
Emergency and Acute Medicine – Adult Asthma
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
Clinical Overview
Adult asthma is a chronic inflammatory airway disorder characterized by increased expiratory resistance due to bronchospasm, mucosal edema, airway inflammation, mucus plugging, and smooth muscle hypertrophy. These processes lead to air trapping, hyperinflation, increased dead space, and progressive airway remodeling. Status asthmaticus refers to a severe exacerbation that fails to respond to standard therapy within 30–60 minutes. Patients at highest risk for life-threatening episodes include those with prior intubations or ICU admissions, chronic systemic steroid use, recent hospitalizations, poor outpatient control, advancing age, limited access to care, multiple comorbidities, and certain demographic factors.
Pathophysiology And Triggers
Asthma involves episodic and usually reversible airflow obstruction with airway hyperresponsiveness driven by a complex inflammatory cascade. Neutrophils, eosinophils, mast cells, macrophages, T lymphocytes, epithelial cells, and cytokines all contribute. Common triggers include environmental allergens such as pollen, dust mites, mold, and animal dander; viral upper respiratory infections; occupational or chemical exposures; tobacco smoke; cold air; exercise; emotional stress; hormonal variation; and medications including aspirin, NSAIDs, and beta-blockers.
Clinical Presentation
Typical symptoms include wheezing, dyspnea, chest tightness, cough, tachypnea, and tachycardia. More severe exacerbations manifest with upright or tripod positioning, accessory muscle use, diaphoresis, inability to speak full sentences, and diminished air movement. Signs of impending respiratory failure include altered mental status, extreme fatigue, and significant pulsus paradoxus.
Diagnostic Assessment
Asthma exacerbation is primarily a clinical diagnosis. Peak expiratory flow rate is useful for quantifying severity and monitoring response to therapy, with values below 100 indicating severe obstruction and values between 100 and 300 reflecting moderate disease. Serial measurements are more informative than single readings. Arterial blood gas testing is not routinely required and should not delay intervention; rising carbon dioxide levels and respiratory acidosis signal exhaustion and impending failure. Pulse oximetry values below 90 percent suggest severe distress, though normal saturation does not exclude imminent collapse. Chest radiography is reserved for selected cases such as suspected pneumonia, pneumothorax, foreign body aspiration, first-time wheezing, or poor response to therapy. ECG is considered when cardiac disease or significant tachyarrhythmia is suspected.
Differential Considerations
Conditions that may mimic asthma include allergic reactions, angioedema, COPD exacerbation, heart failure, pulmonary embolism, pneumonia, upper airway obstruction, foreign body aspiration, myocardial ischemia, and inhalational injury.
Initial Management Principles
Early recognition of severe disease, including the presence of a “quiet chest,” is critical. Immediate therapy includes supplemental oxygen, rapid initiation of inhaled beta-agonists, and early systemic corticosteroids. Intubation should be considered for progressive fatigue, worsening mental status, or refractory hypoxemia.
Emergency Department Management
Oxygen therapy should maintain saturation above 90 percent. Short-acting inhaled beta-2 agonists such as albuterol are first-line and may be administered intermittently for mild to moderate attacks or continuously for severe exacerbations. Subcutaneous beta-agonists may be used when inhaled therapy is inadequate but carry greater systemic risk. Systemic corticosteroids reduce airway inflammation and should be administered early despite delayed onset of action. Anticholinergic agents are beneficial when added to beta-agonists in moderate to severe obstruction. Magnesium sulfate may provide benefit in severe refractory asthma but is not indicated in mild disease. Aminophylline and leukotriene inhibitors are generally not recommended in the acute setting. Noninvasive ventilation and heliox may be considered selectively but should not delay definitive airway management. Ketamine is useful as an induction agent during intubation due to bronchodilatory properties, while permissive hypercapnia may be required during mechanical ventilation.
Disposition And Follow-Up
Hospital admission is indicated for patients with poor peak flow response, persistent respiratory distress, prior severe exacerbations, recent ED visits, prolonged symptoms, or inadequate outpatient support. Observation may be appropriate for moderate responders without distress. Discharge is reasonable when peak flow exceeds 70 percent of predicted, symptoms have clearly improved, lung examination demonstrates good air movement, and close follow-up within 48–72 hours is ensured.
Key Clinical Lessons And Safety Points
Altered mental status in an asthmatic patient signifies ventilatory failure until proven otherwise. Proper inhaler or nebulizer technique must be demonstrated prior to discharge, and peak flow monitoring should be encouraged. Routine intravenous fluids do not improve airway clearance in the absence of dehydration. Antibiotics are rarely indicated and should be reserved for clear evidence of bacterial infection such as pneumonia, fever with purulent sputum, or bacterial sinusitis.
- Published on
Emergency and Acute Medicine – Ascites
Clinical Overview
Ascites refers to the abnormal accumulation of serous fluid within the peritoneal cavity. The most common mechanism is portal hypertension, typically when portal pressures exceed 12 mm Hg, leading to intense renal sodium and water retention. Plasma volume expansion, impaired free-water excretion, and increased antidiuretic hormone release contribute to dilutional hyponatremia, which closely correlates with disease severity and prognosis. Reduced plasma oncotic pressure from hypoalbuminemia further promotes fluid extravasation, while peritoneal irritation from infection, inflammation, or malignancy may also play a role.
Underlying Causes
Parenchymal liver disease accounts for the majority of adult cases, most commonly cirrhosis and alcoholic hepatitis. Other hepatic causes include fulminant hepatic failure and hepatic venous outflow obstruction such as Budd–Chiari syndrome or veno-occlusive disease. Cardiac etiologies include congestive heart failure and constrictive pericarditis. Malignancy-related ascites may arise from peritoneal carcinomatosis or primary and metastatic liver tumors. Infectious causes include tuberculous, fungal, or bacterial peritonitis. Hypoalbuminemic states such as nephrotic syndrome and severe malnutrition may also produce ascites. Less common etiologies include pancreatic or biliary ascites, nephrogenic ascites, ovarian tumors, chylous ascites from lymphatic disruption, connective tissue disease, myxedema, and granulomatous peritonitis. In children, ascites most often results from malignancy, nephrotic syndrome, or malnutrition.
Clinical Features
Patients commonly present with progressive abdominal distention, discomfort, early satiety, weight gain, dyspnea, orthopnea, and peripheral edema. Rapid fluid accumulation is often poorly tolerated. Physical examination may reveal flank fullness, shifting dullness, fluid wave, abdominal hernias, muscle wasting, and signs of the underlying systemic disease. Flank dullness usually becomes evident when at least 500 mL of fluid is present, though detection may be difficult in obese patients.
Diagnostic Approach
Evaluation should focus on identifying liver disease, cardiac dysfunction, malignancy, infection, or systemic illness. Diagnostic paracentesis is essential in all cases of new-onset ascites and is mandatory in patients with fever, abdominal pain, worsening encephalopathy, or clinical deterioration. Ascitic fluid analysis should include cell count with differential, albumin, total protein, Gram stain, culture inoculated into blood culture bottles, glucose, LDH, and additional studies as indicated such as amylase, triglycerides, cytology, bilirubin, and tuberculosis testing.
Spontaneous bacterial peritonitis is defined by ascitic fluid polymorphonuclear leukocytes exceeding 250 cells/mm³ without a surgically correctable intra-abdominal source and often presents with subtle symptoms such as low-grade fever, abdominal discomfort, or altered mentation. Secondary bacterial peritonitis should be suspected when multiple organisms are seen on Gram stain and ascitic fluid demonstrates high protein, low glucose, and markedly elevated LDH.
Laboratory And Imaging Evaluation
Baseline studies include complete blood count, metabolic panel, liver function tests, coagulation profile, arterial blood gas or pulse oximetry, urinalysis, urine sodium, hepatitis serologies, amylase, lipase, alpha-fetoprotein, and thyroid studies when indicated. Ultrasound is useful to confirm ascites, assess abdominal organs, and guide paracentesis, particularly in low-volume cases. Doppler imaging evaluates hepatic blood flow, while CT scanning and chest radiography may identify malignancy, heart failure, or pulmonary complications.
The serum–ascites albumin gradient is a key diagnostic tool. A gradient of 1.1 g/dL or greater strongly suggests portal hypertension, whereas a lower gradient points toward malignancy, infection, pancreatic disease, or nephrotic syndrome.
Management Principles
Treatment depends on the underlying cause and aims to reduce ascitic volume while preserving effective intravascular circulation. Sudden abdominal pain, fever, or rapid distention warrants urgent reassessment for infection, hepatocellular carcinoma, hepatic outflow obstruction, or acute decompensation. Therapeutic paracentesis is indicated for tense ascites or respiratory compromise and can safely remove large volumes when hemodynamics are stable. Albumin replacement should be considered when more than 5 liters are removed.
Long-term control includes strict dietary sodium restriction and judicious use of diuretics. Spironolactone is preferred for cirrhotic ascites, often combined with furosemide in a fixed ratio. Weight loss targets should be conservative, and renal function and electrolytes must be closely monitored. Refractory ascites may require transjugular intrahepatic portosystemic shunting or liver transplantation. Nonsteroidal anti-inflammatory drugs should be avoided due to adverse renal effects and sodium retention.
Disposition And Follow-Up
Hospital admission is required for patients with spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, fulminant liver failure, or refractory tense ascites. Stable patients who respond to emergency management may be discharged with close follow-up. All new cases warrant gastroenterology evaluation, while established cases should continue coordinated outpatient care.
Clinical Insights And Common Pitfalls
New-onset ascites always requires a complete diagnostic evaluation and specialist involvement. Symptoms of spontaneous bacterial peritonitis are frequently subtle, demanding a low threshold for paracentesis. Coagulopathy alone is not a contraindication to paracentesis, as diagnostic benefit outweighs bleeding risk. Ultrasound guidance improves safety and success, particularly in patients with small-volume ascites.
Clinical Overview
Ascites refers to the abnormal accumulation of serous fluid within the peritoneal cavity. The most common mechanism is portal hypertension, typically when portal pressures exceed 12 mm Hg, leading to intense renal sodium and water retention. Plasma volume expansion, impaired free-water excretion, and increased antidiuretic hormone release contribute to dilutional hyponatremia, which closely correlates with disease severity and prognosis. Reduced plasma oncotic pressure from hypoalbuminemia further promotes fluid extravasation, while peritoneal irritation from infection, inflammation, or malignancy may also play a role.
Underlying Causes
Parenchymal liver disease accounts for the majority of adult cases, most commonly cirrhosis and alcoholic hepatitis. Other hepatic causes include fulminant hepatic failure and hepatic venous outflow obstruction such as Budd–Chiari syndrome or veno-occlusive disease. Cardiac etiologies include congestive heart failure and constrictive pericarditis. Malignancy-related ascites may arise from peritoneal carcinomatosis or primary and metastatic liver tumors. Infectious causes include tuberculous, fungal, or bacterial peritonitis. Hypoalbuminemic states such as nephrotic syndrome and severe malnutrition may also produce ascites. Less common etiologies include pancreatic or biliary ascites, nephrogenic ascites, ovarian tumors, chylous ascites from lymphatic disruption, connective tissue disease, myxedema, and granulomatous peritonitis. In children, ascites most often results from malignancy, nephrotic syndrome, or malnutrition.
Clinical Features
Patients commonly present with progressive abdominal distention, discomfort, early satiety, weight gain, dyspnea, orthopnea, and peripheral edema. Rapid fluid accumulation is often poorly tolerated. Physical examination may reveal flank fullness, shifting dullness, fluid wave, abdominal hernias, muscle wasting, and signs of the underlying systemic disease. Flank dullness usually becomes evident when at least 500 mL of fluid is present, though detection may be difficult in obese patients.
Diagnostic Approach
Evaluation should focus on identifying liver disease, cardiac dysfunction, malignancy, infection, or systemic illness. Diagnostic paracentesis is essential in all cases of new-onset ascites and is mandatory in patients with fever, abdominal pain, worsening encephalopathy, or clinical deterioration. Ascitic fluid analysis should include cell count with differential, albumin, total protein, Gram stain, culture inoculated into blood culture bottles, glucose, LDH, and additional studies as indicated such as amylase, triglycerides, cytology, bilirubin, and tuberculosis testing.
Spontaneous bacterial peritonitis is defined by ascitic fluid polymorphonuclear leukocytes exceeding 250 cells/mm³ without a surgically correctable intra-abdominal source and often presents with subtle symptoms such as low-grade fever, abdominal discomfort, or altered mentation. Secondary bacterial peritonitis should be suspected when multiple organisms are seen on Gram stain and ascitic fluid demonstrates high protein, low glucose, and markedly elevated LDH.
Laboratory And Imaging Evaluation
Baseline studies include complete blood count, metabolic panel, liver function tests, coagulation profile, arterial blood gas or pulse oximetry, urinalysis, urine sodium, hepatitis serologies, amylase, lipase, alpha-fetoprotein, and thyroid studies when indicated. Ultrasound is useful to confirm ascites, assess abdominal organs, and guide paracentesis, particularly in low-volume cases. Doppler imaging evaluates hepatic blood flow, while CT scanning and chest radiography may identify malignancy, heart failure, or pulmonary complications.
The serum–ascites albumin gradient is a key diagnostic tool. A gradient of 1.1 g/dL or greater strongly suggests portal hypertension, whereas a lower gradient points toward malignancy, infection, pancreatic disease, or nephrotic syndrome.
Management Principles
Treatment depends on the underlying cause and aims to reduce ascitic volume while preserving effective intravascular circulation. Sudden abdominal pain, fever, or rapid distention warrants urgent reassessment for infection, hepatocellular carcinoma, hepatic outflow obstruction, or acute decompensation. Therapeutic paracentesis is indicated for tense ascites or respiratory compromise and can safely remove large volumes when hemodynamics are stable. Albumin replacement should be considered when more than 5 liters are removed.
Long-term control includes strict dietary sodium restriction and judicious use of diuretics. Spironolactone is preferred for cirrhotic ascites, often combined with furosemide in a fixed ratio. Weight loss targets should be conservative, and renal function and electrolytes must be closely monitored. Refractory ascites may require transjugular intrahepatic portosystemic shunting or liver transplantation. Nonsteroidal anti-inflammatory drugs should be avoided due to adverse renal effects and sodium retention.
Disposition And Follow-Up
Hospital admission is required for patients with spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, fulminant liver failure, or refractory tense ascites. Stable patients who respond to emergency management may be discharged with close follow-up. All new cases warrant gastroenterology evaluation, while established cases should continue coordinated outpatient care.
Clinical Insights And Common Pitfalls
New-onset ascites always requires a complete diagnostic evaluation and specialist involvement. Symptoms of spontaneous bacterial peritonitis are frequently subtle, demanding a low threshold for paracentesis. Coagulopathy alone is not a contraindication to paracentesis, as diagnostic benefit outweighs bleeding risk. Ultrasound guidance improves safety and success, particularly in patients with small-volume ascites.
- Published on
Emergency and Acute Medicine – Septic Arthritis
Clinical Overview
Septic arthritis is an acute, destructive joint infection most commonly caused by bacterial seeding of the synovial space through hematogenous spread, though direct inoculation, invasive procedures, or contiguous spread from adjacent infection may also occur. The inflammatory response leads to rapid leukocyte migration into the joint, synovial proliferation, cartilage destruction, and purulent effusion. Permanent loss of joint function occurs in a substantial proportion of patients, and reported mortality remains significant. Early recognition and intervention are therefore critical.
In children, the hip is the most frequently involved joint, often following upper respiratory or ear infections or femoral venipuncture. Infants may present nonspecifically with irritability, fever, and poor feeding, whereas older children more commonly present with fever, limp, or refusal to bear weight. Pediatric hip infections carry a high risk of serious complications including avascular necrosis, epiphyseal separation, pathologic dislocation, and early degenerative arthritis.
Predisposing Factors And Microbiology
Risk is increased at the extremes of age, in patients with underlying joint disease such as rheumatoid or degenerative arthritis, intravenous drug use, endocarditis, immunosuppression, diabetes, malignancy, chronic steroid use, recent joint injections, trauma, prosthetic joints, or overlying skin infection. No organism is identified in a minority of cases.
Staphylococcus aureus remains the most common pathogen overall, particularly in adults, hip infections, and patients with rheumatoid arthritis or diabetes. Community-acquired MRSA is increasingly prevalent in some regions. Neisseria gonorrhoeae is the leading cause in young, sexually active individuals, often presenting with disseminated disease. Other causative organisms include streptococcal species, gram-negative rods such as Pseudomonas and Escherichia coli, Neisseria meningitidis, anaerobes, and, less commonly, mycobacteria or fungi in immunocompromised hosts.
Clinical Presentation
Septic arthritis typically presents with abrupt onset of severe joint pain, swelling, warmth, and marked tenderness, with pain on both active and passive movement. Fever is common but may be absent, particularly in older adults or those with rheumatoid arthritis. Joint effusion may be subtle in deep joints such as the hip, shoulder, or sacroiliac joint. Although any joint may be involved, the knee is most common, followed by the hip, shoulder, and ankle. Intravenous drug users frequently develop infections in atypical sites including the sacroiliac, sternoclavicular, and costochondral joints.
Polyarticular involvement occurs in a minority of cases and is more frequent in patients with rheumatoid arthritis, often leading to delayed diagnosis due to less dramatic presentations. Gonococcal septic arthritis may be monoarticular or migratory and is frequently associated with tenosynovitis, dermatitis, and subtle genitourinary symptoms.
Diagnostic Strategy
Prompt arthrocentesis is essential in all suspected cases and should not be delayed. Synovial fluid should be analyzed for cell count, differential, Gram stain, culture, glucose, and protein. Typical findings include turbid or purulent fluid with very high leukocyte counts and neutrophil predominance. Reduced synovial glucose and elevated protein further support infection. The presence of crystals does not exclude septic arthritis. Blood cultures are frequently positive and should be obtained, along with cultures from suspected primary infection sites when appropriate.
Serum inflammatory markers such as CRP and ESR are usually elevated and may assist in monitoring response to therapy. Procalcitonin may be useful as a supportive diagnostic marker. Imaging with plain radiographs helps assess baseline joint status and detect effusions, osteomyelitis, or foreign bodies. Ultrasound is valuable for detecting effusions and guiding aspiration, particularly in the hip. CT or MRI may be necessary for deep or difficult-to-access joints.
Management Principles
Patients may present septic and require immediate resuscitation. Joint aspiration should be performed promptly, but in toxic patients antibiotics should not be delayed while awaiting results. Empiric intravenous antibiotics should be initiated based on patient age, risk factors, and local resistance patterns, with coverage for staphylococci, streptococci, and gram-negative organisms as indicated. MRSA coverage should be included when risk factors are present. Suspected gonococcal infection should be treated with appropriate cephalosporins. Intra-articular antibiotics are contraindicated.
Early orthopedic consultation is essential to determine the need for surgical drainage, which may involve repeated aspirations, arthroscopy, or open arthrotomy. Pediatric hip infections typically require open surgical drainage. Adequate pain control and joint positioning to minimize further damage are important supportive measures.
Disposition And Follow-Up
All patients with suspected septic arthritis should be admitted until the diagnosis is confidently excluded. Most require prolonged intravenous antibiotic therapy and possible surgical intervention. Discharge is appropriate only when infection has been reliably ruled out. Close follow-up is required to monitor clinical response and prevent long-term complications.
Key Clinical Lessons And Common Errors
Inflammatory markers such as CRP and ESR are useful for tracking treatment response but should not replace synovial fluid analysis for diagnosis. Distinguishing septic arthritis from crystal arthropathy or transient synovitis can be challenging; when in doubt, joint aspiration is mandatory. A low threshold for arthrocentesis is essential to avoid delayed diagnosis and irreversible joint damage.
Clinical Overview
Septic arthritis is an acute, destructive joint infection most commonly caused by bacterial seeding of the synovial space through hematogenous spread, though direct inoculation, invasive procedures, or contiguous spread from adjacent infection may also occur. The inflammatory response leads to rapid leukocyte migration into the joint, synovial proliferation, cartilage destruction, and purulent effusion. Permanent loss of joint function occurs in a substantial proportion of patients, and reported mortality remains significant. Early recognition and intervention are therefore critical.
In children, the hip is the most frequently involved joint, often following upper respiratory or ear infections or femoral venipuncture. Infants may present nonspecifically with irritability, fever, and poor feeding, whereas older children more commonly present with fever, limp, or refusal to bear weight. Pediatric hip infections carry a high risk of serious complications including avascular necrosis, epiphyseal separation, pathologic dislocation, and early degenerative arthritis.
Predisposing Factors And Microbiology
Risk is increased at the extremes of age, in patients with underlying joint disease such as rheumatoid or degenerative arthritis, intravenous drug use, endocarditis, immunosuppression, diabetes, malignancy, chronic steroid use, recent joint injections, trauma, prosthetic joints, or overlying skin infection. No organism is identified in a minority of cases.
Staphylococcus aureus remains the most common pathogen overall, particularly in adults, hip infections, and patients with rheumatoid arthritis or diabetes. Community-acquired MRSA is increasingly prevalent in some regions. Neisseria gonorrhoeae is the leading cause in young, sexually active individuals, often presenting with disseminated disease. Other causative organisms include streptococcal species, gram-negative rods such as Pseudomonas and Escherichia coli, Neisseria meningitidis, anaerobes, and, less commonly, mycobacteria or fungi in immunocompromised hosts.
Clinical Presentation
Septic arthritis typically presents with abrupt onset of severe joint pain, swelling, warmth, and marked tenderness, with pain on both active and passive movement. Fever is common but may be absent, particularly in older adults or those with rheumatoid arthritis. Joint effusion may be subtle in deep joints such as the hip, shoulder, or sacroiliac joint. Although any joint may be involved, the knee is most common, followed by the hip, shoulder, and ankle. Intravenous drug users frequently develop infections in atypical sites including the sacroiliac, sternoclavicular, and costochondral joints.
Polyarticular involvement occurs in a minority of cases and is more frequent in patients with rheumatoid arthritis, often leading to delayed diagnosis due to less dramatic presentations. Gonococcal septic arthritis may be monoarticular or migratory and is frequently associated with tenosynovitis, dermatitis, and subtle genitourinary symptoms.
Diagnostic Strategy
Prompt arthrocentesis is essential in all suspected cases and should not be delayed. Synovial fluid should be analyzed for cell count, differential, Gram stain, culture, glucose, and protein. Typical findings include turbid or purulent fluid with very high leukocyte counts and neutrophil predominance. Reduced synovial glucose and elevated protein further support infection. The presence of crystals does not exclude septic arthritis. Blood cultures are frequently positive and should be obtained, along with cultures from suspected primary infection sites when appropriate.
Serum inflammatory markers such as CRP and ESR are usually elevated and may assist in monitoring response to therapy. Procalcitonin may be useful as a supportive diagnostic marker. Imaging with plain radiographs helps assess baseline joint status and detect effusions, osteomyelitis, or foreign bodies. Ultrasound is valuable for detecting effusions and guiding aspiration, particularly in the hip. CT or MRI may be necessary for deep or difficult-to-access joints.
Management Principles
Patients may present septic and require immediate resuscitation. Joint aspiration should be performed promptly, but in toxic patients antibiotics should not be delayed while awaiting results. Empiric intravenous antibiotics should be initiated based on patient age, risk factors, and local resistance patterns, with coverage for staphylococci, streptococci, and gram-negative organisms as indicated. MRSA coverage should be included when risk factors are present. Suspected gonococcal infection should be treated with appropriate cephalosporins. Intra-articular antibiotics are contraindicated.
Early orthopedic consultation is essential to determine the need for surgical drainage, which may involve repeated aspirations, arthroscopy, or open arthrotomy. Pediatric hip infections typically require open surgical drainage. Adequate pain control and joint positioning to minimize further damage are important supportive measures.
Disposition And Follow-Up
All patients with suspected septic arthritis should be admitted until the diagnosis is confidently excluded. Most require prolonged intravenous antibiotic therapy and possible surgical intervention. Discharge is appropriate only when infection has been reliably ruled out. Close follow-up is required to monitor clinical response and prevent long-term complications.
Key Clinical Lessons And Common Errors
Inflammatory markers such as CRP and ESR are useful for tracking treatment response but should not replace synovial fluid analysis for diagnosis. Distinguishing septic arthritis from crystal arthropathy or transient synovitis can be challenging; when in doubt, joint aspiration is mandatory. A low threshold for arthrocentesis is essential to avoid delayed diagnosis and irreversible joint damage.
- Published on
Emergency and Acute Medicine – Rheumatoid Arthritis
Clinical Overview
Rheumatoid arthritis is a chronic, systemic inflammatory disease characterized by persistent, noninfectious synovitis that leads to progressive destruction of articular cartilage, joint deformity, and eventual ankylosis. The disease most commonly affects peripheral joints in a symmetric pattern and is associated with significant extra-articular involvement. Knee involvement is frequent, and chronic inflammation may result in Baker cyst formation. Axial disease is typically limited to the cervical spine, where atlantoaxial subluxation may occur and, rarely, cause spinal cord compression. Rheumatoid arthritis is distinct from juvenile idiopathic arthritis, which represents a separate pediatric condition.
Epidemiology And Pathogenesis
The etiology remains unknown, though autoimmune mechanisms likely triggered by environmental factors in genetically predisposed individuals are implicated. An association with HLA-DR4 has been identified. The condition affects approximately 1% of the global population, with a female predominance of roughly 3:1. Onset most commonly occurs between 30 and 50 years of age.
Clinical Manifestations
Early symptoms are often nonspecific and include fatigue, malaise, and diffuse musculoskeletal discomfort. Over weeks to months, patients develop warm, swollen, painful joints, classically worse in the morning with stiffness lasting longer than one hour. Joint involvement is usually symmetric and polyarticular, beginning in the small joints of the hands and feet and later involving the wrists, elbows, and knees. Distal interphalangeal joint involvement is uncommon and should prompt consideration of alternative diagnoses. Synovitis progresses gradually, and long-standing disease leads to characteristic deformities such as ulnar deviation of the metacarpophalangeal joints, swan-neck deformities, and boutonnière deformities.
Extra-articular manifestations are common and include subcutaneous rheumatoid nodules, vasculitis, pericarditis or myocarditis, pulmonary fibrosis or pneumonitis, Sjögren syndrome, and mononeuritis multiplex. Mild pericarditis may be present in a significant proportion of patients and may warrant electrocardiographic evaluation. Emergency department presentations often relate to disease flares or complications affecting other organ systems, including airway compromise from cricoarytenoid arthritis, cardiac conduction abnormalities, pulmonary disease, hepatic involvement, or neurologic deficits related to cervical spine instability. Ocular complications such as scleritis, episcleritis, iritis, or retinal vasculitis should be suspected in patients with red eye, photophobia, or vision changes and require urgent ophthalmologic evaluation. Chronic medication use may result in infections, osteopenia, fractures, metabolic disturbances, glaucoma, cataracts, or gastrointestinal bleeding.
Diagnostic Approach In The Emergency Setting
A definitive diagnosis of rheumatoid arthritis is rarely established in the emergency department. Diagnostic criteria require synovitis lasting at least six weeks and fulfillment of established classification criteria. Emergency evaluation should instead focus on excluding alternative or immediately life-threatening causes of arthritis, particularly septic arthritis, gout, or reactive arthritis. Arthrocentesis is indicated when infection or crystal-induced disease is a concern. A careful history should assess systemic symptoms such as weight loss, fever, weakness, bursitis, or tendonitis.
Laboratory And Imaging Evaluation
Laboratory studies may reveal mild anemia, leukocytosis, thrombocytosis, elevated erythrocyte sedimentation rate, and increased C-reactive protein, which correlates with erosive disease. Rheumatoid factor is positive in the majority of patients, while antinuclear antibodies may be present in a subset. Synovial fluid analysis typically shows an inflammatory profile with elevated white blood cell counts and neutrophil predominance, without organisms or crystals. Imaging may demonstrate joint effusions, juxta-articular erosions, joint space narrowing, and loss of cartilage. MRI can detect early inflammatory changes before radiographic abnormalities. Chest imaging may reveal pulmonary or cardiac involvement, and cervical spine imaging is important when neurologic symptoms or airway concerns are present.
Management Principles
Prehospital and emergency care priorities include airway management with cervical spine protection when indicated and treatment of acute complications. Nonsteroidal anti-inflammatory drugs and salicylates are first-line agents for symptom control in acute settings, recognizing that early disease may progress rapidly. Glucocorticoids, disease-modifying antirheumatic drugs, and biologic agents should generally be initiated or adjusted in consultation with a rheumatologist rather than started de novo in the emergency department. Pain control and supportive care are essential, while careful attention must be paid to medication side effects and comorbid conditions.
Disposition And Follow-Up
Hospital admission is warranted for patients with severe or life-threatening complications, unclear diagnoses where serious alternative conditions cannot be excluded, uncontrolled pain, significant functional impairment, or inadequate social support. Pediatric patients presenting with fever and arthritis require a low threshold for admission. Stable patients without complications may be discharged with appropriate outpatient management and close follow-up. Ongoing care should involve coordination with primary care and specialty services, including rheumatology, cardiology, ophthalmology, and orthopedics as indicated.
Clinical Insights And Diagnostic Pitfalls
Symmetric inflammatory arthritis strongly suggests rheumatoid arthritis, but the presence of this diagnosis does not exclude superimposed septic arthritis, which must always be considered. Disease-modifying therapies and biologic agents should not be initiated in the emergency department without specialist input. Careful evaluation for cervical spine instability and extra-articular complications is essential, as these may present with subtle but high-risk features.
Clinical Overview
Rheumatoid arthritis is a chronic, systemic inflammatory disease characterized by persistent, noninfectious synovitis that leads to progressive destruction of articular cartilage, joint deformity, and eventual ankylosis. The disease most commonly affects peripheral joints in a symmetric pattern and is associated with significant extra-articular involvement. Knee involvement is frequent, and chronic inflammation may result in Baker cyst formation. Axial disease is typically limited to the cervical spine, where atlantoaxial subluxation may occur and, rarely, cause spinal cord compression. Rheumatoid arthritis is distinct from juvenile idiopathic arthritis, which represents a separate pediatric condition.
Epidemiology And Pathogenesis
The etiology remains unknown, though autoimmune mechanisms likely triggered by environmental factors in genetically predisposed individuals are implicated. An association with HLA-DR4 has been identified. The condition affects approximately 1% of the global population, with a female predominance of roughly 3:1. Onset most commonly occurs between 30 and 50 years of age.
Clinical Manifestations
Early symptoms are often nonspecific and include fatigue, malaise, and diffuse musculoskeletal discomfort. Over weeks to months, patients develop warm, swollen, painful joints, classically worse in the morning with stiffness lasting longer than one hour. Joint involvement is usually symmetric and polyarticular, beginning in the small joints of the hands and feet and later involving the wrists, elbows, and knees. Distal interphalangeal joint involvement is uncommon and should prompt consideration of alternative diagnoses. Synovitis progresses gradually, and long-standing disease leads to characteristic deformities such as ulnar deviation of the metacarpophalangeal joints, swan-neck deformities, and boutonnière deformities.
Extra-articular manifestations are common and include subcutaneous rheumatoid nodules, vasculitis, pericarditis or myocarditis, pulmonary fibrosis or pneumonitis, Sjögren syndrome, and mononeuritis multiplex. Mild pericarditis may be present in a significant proportion of patients and may warrant electrocardiographic evaluation. Emergency department presentations often relate to disease flares or complications affecting other organ systems, including airway compromise from cricoarytenoid arthritis, cardiac conduction abnormalities, pulmonary disease, hepatic involvement, or neurologic deficits related to cervical spine instability. Ocular complications such as scleritis, episcleritis, iritis, or retinal vasculitis should be suspected in patients with red eye, photophobia, or vision changes and require urgent ophthalmologic evaluation. Chronic medication use may result in infections, osteopenia, fractures, metabolic disturbances, glaucoma, cataracts, or gastrointestinal bleeding.
Diagnostic Approach In The Emergency Setting
A definitive diagnosis of rheumatoid arthritis is rarely established in the emergency department. Diagnostic criteria require synovitis lasting at least six weeks and fulfillment of established classification criteria. Emergency evaluation should instead focus on excluding alternative or immediately life-threatening causes of arthritis, particularly septic arthritis, gout, or reactive arthritis. Arthrocentesis is indicated when infection or crystal-induced disease is a concern. A careful history should assess systemic symptoms such as weight loss, fever, weakness, bursitis, or tendonitis.
Laboratory And Imaging Evaluation
Laboratory studies may reveal mild anemia, leukocytosis, thrombocytosis, elevated erythrocyte sedimentation rate, and increased C-reactive protein, which correlates with erosive disease. Rheumatoid factor is positive in the majority of patients, while antinuclear antibodies may be present in a subset. Synovial fluid analysis typically shows an inflammatory profile with elevated white blood cell counts and neutrophil predominance, without organisms or crystals. Imaging may demonstrate joint effusions, juxta-articular erosions, joint space narrowing, and loss of cartilage. MRI can detect early inflammatory changes before radiographic abnormalities. Chest imaging may reveal pulmonary or cardiac involvement, and cervical spine imaging is important when neurologic symptoms or airway concerns are present.
Management Principles
Prehospital and emergency care priorities include airway management with cervical spine protection when indicated and treatment of acute complications. Nonsteroidal anti-inflammatory drugs and salicylates are first-line agents for symptom control in acute settings, recognizing that early disease may progress rapidly. Glucocorticoids, disease-modifying antirheumatic drugs, and biologic agents should generally be initiated or adjusted in consultation with a rheumatologist rather than started de novo in the emergency department. Pain control and supportive care are essential, while careful attention must be paid to medication side effects and comorbid conditions.
Disposition And Follow-Up
Hospital admission is warranted for patients with severe or life-threatening complications, unclear diagnoses where serious alternative conditions cannot be excluded, uncontrolled pain, significant functional impairment, or inadequate social support. Pediatric patients presenting with fever and arthritis require a low threshold for admission. Stable patients without complications may be discharged with appropriate outpatient management and close follow-up. Ongoing care should involve coordination with primary care and specialty services, including rheumatology, cardiology, ophthalmology, and orthopedics as indicated.
Clinical Insights And Diagnostic Pitfalls
Symmetric inflammatory arthritis strongly suggests rheumatoid arthritis, but the presence of this diagnosis does not exclude superimposed septic arthritis, which must always be considered. Disease-modifying therapies and biologic agents should not be initiated in the emergency department without specialist input. Careful evaluation for cervical spine instability and extra-articular complications is essential, as these may present with subtle but high-risk features.
- Published on
Emergency and Acute Medicine – Monoarticular Arthritis
Clinical Overview
Monoarticular arthritis refers to inflammation confined to a single joint and is never migratory. The presence of one cause does not exclude another, and rapid identification of the underlying etiology is critical because outcomes range from benign self-limited disease to rapidly destructive infection with permanent disability. Causes broadly include infectious, crystalline, inflammatory, and noninflammatory processes, each with distinct urgency and management priorities.
Pathophysiology And Etiologic Categories
Septic arthritis represents the most time-sensitive cause, as bacterial invasion of the joint leads to rapid cartilage destruction. Infection may arise from hematogenous spread, contiguous extension from nearby soft tissue or bone, or direct inoculation through trauma or procedures. Risk is increased in patients with immunosuppression, intravenous drug use, preexisting joint disease, or prosthetic joints. Crystalline arthritis includes gout, caused by monosodium urate deposition from overproduction or underexcretion of uric acid, and pseudogout, caused by calcium pyrophosphate deposition. Inflammatory causes include rheumatoid arthritis, psoriatic arthritis, and reactive arthritis, where monoarticular involvement may be an early manifestation. Noninflammatory etiologies encompass osteoarthritis, trauma, hemarthrosis, neuropathic joints, and mechanical overload.
Pediatric-Specific Considerations
In children, septic arthritis is uncommon but carries high morbidity and requires immediate intervention. The hip and knee are most frequently affected, often with coexisting osteomyelitis. Any child presenting with an acutely swollen, painful joint and systemic symptoms mandates urgent aspiration, empiric antibiotics, and hospital admission. Noninfectious causes in children include epiphyseal plate injuries, congenital hip disorders, slipped capital femoral epiphysis in overweight adolescents, Legg–Calvé–Perthes disease, and bleeding disorders.
Clinical Presentation And History
Patients typically present with acute joint pain, swelling, warmth, erythema, and reduced range of motion, often refusing to bear weight. Septic arthritis commonly presents with fever and systemic illness, with large joints such as the knee and hip most often involved. Gonococcal arthritis may be associated with urethral symptoms, while Lyme arthritis often presents with knee swelling and a history of tick exposure. Gout manifests as sudden, severe pain with recurrent self-limited flares, classically affecting the first metatarsophalangeal joint, whereas pseudogout more often involves the knee or wrist. Degenerative disease presents with stiffness after inactivity and pain with use, while neuropathic joints may show profound destruction with surprisingly little pain. A thorough history should address prior joint disease, systemic illnesses, immune status, medication use, substance use, sexual history, and trauma.
Physical Examination
Examination focuses on confirming true intra-articular pathology, assessing neurovascular status, identifying signs of systemic illness, and evaluating for features suggestive of chronic disease such as muscle atrophy or skin changes. Pain with both active and passive motion strongly suggests intra-articular involvement.
Diagnostic Strategy
Accurate and timely diagnosis reduces morbidity and preserves function. Arthrocentesis with synovial fluid analysis is the cornerstone of evaluation and should be performed promptly unless contraindicated. Blood tests alone are insufficient for diagnosis and serve only as supportive data.
Laboratory And Imaging Evaluation
Synovial fluid analysis provides definitive diagnostic information. High white blood cell counts with neutrophil predominance increase suspicion for infection, particularly when exceeding 50,000 cells/mm³. Synovial glucose significantly lower than serum levels supports septic arthritis. Gram stain guides early antibiotic selection, while culture confirms the organism. Crystal analysis under polarized light identifies gout or pseudogout. Imaging with plain radiographs assesses fractures, chronic joint changes, and effusions, while ultrasound assists in detecting fluid collections and guiding aspiration. MRI is reserved for suspected occult fracture, osteonecrosis, or deep infection.
Management Principles
Initial care includes joint immobilization in a position of comfort, vascular access, analgesia, and early aspiration. Septic arthritis requires immediate empiric intravenous antibiotics and urgent orthopedic consultation, often followed by surgical irrigation. Crystalline arthritis management focuses first on controlling the acute flare with NSAIDs, colchicine, or corticosteroids, followed later by prophylactic and urate-lowering therapy once the flare resolves. Noninflammatory causes are managed with analgesia, anti-inflammatory agents, physical therapy, and orthopedic intervention when indicated. Hemorrhagic arthritis requires correction of underlying coagulopathy.
Disposition And Follow-Up
Admission is required for all cases of septic arthritis, patients unable to perform activities of daily living, those with systemic illness, metabolic derangements, intractable pain, or joints requiring surgical intervention. Discharge may be appropriate when symptoms are controlled, comorbidities are stable, medications are accessible, and reliable follow-up is ensured. Prompt referral to appropriate specialists is essential for definitive management.
Key Clinical Insights And Diagnostic Traps
Synovial fluid aspiration with Gram stain and analysis is the single most important diagnostic step and should not be delayed. Septic arthritis must be assumed until definitively excluded, particularly in patients with diabetes, immunosuppression, recent joint injections, trauma, or overlying cellulitis. Intra-articular corticosteroids should never be administered until infection has been ruled out, as this may worsen outcomes and obscure diagnosis.
Clinical Overview
Monoarticular arthritis refers to inflammation confined to a single joint and is never migratory. The presence of one cause does not exclude another, and rapid identification of the underlying etiology is critical because outcomes range from benign self-limited disease to rapidly destructive infection with permanent disability. Causes broadly include infectious, crystalline, inflammatory, and noninflammatory processes, each with distinct urgency and management priorities.
Pathophysiology And Etiologic Categories
Septic arthritis represents the most time-sensitive cause, as bacterial invasion of the joint leads to rapid cartilage destruction. Infection may arise from hematogenous spread, contiguous extension from nearby soft tissue or bone, or direct inoculation through trauma or procedures. Risk is increased in patients with immunosuppression, intravenous drug use, preexisting joint disease, or prosthetic joints. Crystalline arthritis includes gout, caused by monosodium urate deposition from overproduction or underexcretion of uric acid, and pseudogout, caused by calcium pyrophosphate deposition. Inflammatory causes include rheumatoid arthritis, psoriatic arthritis, and reactive arthritis, where monoarticular involvement may be an early manifestation. Noninflammatory etiologies encompass osteoarthritis, trauma, hemarthrosis, neuropathic joints, and mechanical overload.
Pediatric-Specific Considerations
In children, septic arthritis is uncommon but carries high morbidity and requires immediate intervention. The hip and knee are most frequently affected, often with coexisting osteomyelitis. Any child presenting with an acutely swollen, painful joint and systemic symptoms mandates urgent aspiration, empiric antibiotics, and hospital admission. Noninfectious causes in children include epiphyseal plate injuries, congenital hip disorders, slipped capital femoral epiphysis in overweight adolescents, Legg–Calvé–Perthes disease, and bleeding disorders.
Clinical Presentation And History
Patients typically present with acute joint pain, swelling, warmth, erythema, and reduced range of motion, often refusing to bear weight. Septic arthritis commonly presents with fever and systemic illness, with large joints such as the knee and hip most often involved. Gonococcal arthritis may be associated with urethral symptoms, while Lyme arthritis often presents with knee swelling and a history of tick exposure. Gout manifests as sudden, severe pain with recurrent self-limited flares, classically affecting the first metatarsophalangeal joint, whereas pseudogout more often involves the knee or wrist. Degenerative disease presents with stiffness after inactivity and pain with use, while neuropathic joints may show profound destruction with surprisingly little pain. A thorough history should address prior joint disease, systemic illnesses, immune status, medication use, substance use, sexual history, and trauma.
Physical Examination
Examination focuses on confirming true intra-articular pathology, assessing neurovascular status, identifying signs of systemic illness, and evaluating for features suggestive of chronic disease such as muscle atrophy or skin changes. Pain with both active and passive motion strongly suggests intra-articular involvement.
Diagnostic Strategy
Accurate and timely diagnosis reduces morbidity and preserves function. Arthrocentesis with synovial fluid analysis is the cornerstone of evaluation and should be performed promptly unless contraindicated. Blood tests alone are insufficient for diagnosis and serve only as supportive data.
Laboratory And Imaging Evaluation
Synovial fluid analysis provides definitive diagnostic information. High white blood cell counts with neutrophil predominance increase suspicion for infection, particularly when exceeding 50,000 cells/mm³. Synovial glucose significantly lower than serum levels supports septic arthritis. Gram stain guides early antibiotic selection, while culture confirms the organism. Crystal analysis under polarized light identifies gout or pseudogout. Imaging with plain radiographs assesses fractures, chronic joint changes, and effusions, while ultrasound assists in detecting fluid collections and guiding aspiration. MRI is reserved for suspected occult fracture, osteonecrosis, or deep infection.
Management Principles
Initial care includes joint immobilization in a position of comfort, vascular access, analgesia, and early aspiration. Septic arthritis requires immediate empiric intravenous antibiotics and urgent orthopedic consultation, often followed by surgical irrigation. Crystalline arthritis management focuses first on controlling the acute flare with NSAIDs, colchicine, or corticosteroids, followed later by prophylactic and urate-lowering therapy once the flare resolves. Noninflammatory causes are managed with analgesia, anti-inflammatory agents, physical therapy, and orthopedic intervention when indicated. Hemorrhagic arthritis requires correction of underlying coagulopathy.
Disposition And Follow-Up
Admission is required for all cases of septic arthritis, patients unable to perform activities of daily living, those with systemic illness, metabolic derangements, intractable pain, or joints requiring surgical intervention. Discharge may be appropriate when symptoms are controlled, comorbidities are stable, medications are accessible, and reliable follow-up is ensured. Prompt referral to appropriate specialists is essential for definitive management.
Key Clinical Insights And Diagnostic Traps
Synovial fluid aspiration with Gram stain and analysis is the single most important diagnostic step and should not be delayed. Septic arthritis must be assumed until definitively excluded, particularly in patients with diabetes, immunosuppression, recent joint injections, trauma, or overlying cellulitis. Intra-articular corticosteroids should never be administered until infection has been ruled out, as this may worsen outcomes and obscure diagnosis.
- Published on
Emergency and Acute Medicine – Juvenile Idiopathic Arthritis
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
Overview And Definition
Juvenile idiopathic arthritis (JIA), formerly termed juvenile rheumatoid arthritis, represents a group of chronic inflammatory arthritides beginning before 17 years of age and persisting for more than six weeks without an identifiable cause. It is the most common chronic rheumatologic disease of childhood, affecting up to 1 in 1,000 children, with a female predominance in most subtypes. JIA encompasses a heterogeneous spectrum of disease, and fewer than half of affected children achieve complete remission, with many experiencing relapsing or persistent disease into adulthood.
Pathophysiology And Disease Classification
JIA is believed to result from immune dysregulation triggered by environmental factors in genetically predisposed children. The condition is classified into several subtypes based on joint involvement, symmetry, systemic features, laboratory findings, and family history. These include systemic-onset, pauciarticular, polyarticular (RF-positive and RF-negative), psoriatic, enthesitis-related, and unclassified forms. Prognosis varies by subtype, with pauciarticular disease generally carrying the most favorable outcome.
Clinical Subtypes And Presentations
Systemic-onset JIA accounts for a minority of cases and affects boys and girls equally. It is characterized by high, quotidian fevers lasting longer than two weeks, often accompanied by arthritis that may appear weeks to months after fever onset. Additional features may include a transient salmon-colored rash, lymphadenopathy, hepatosplenomegaly, or serositis. These patients often appear acutely ill and are at significant risk for macrophage activation syndrome, a life-threatening hyperinflammatory condition with high mortality.
Pauciarticular JIA is the most common subtype and typically affects young girls between two and four years of age. It involves four or fewer joints within the first six months, most often the knees, and presents insidiously in otherwise well-appearing children. Uveitis occurs in a substantial proportion and may be asymptomatic, necessitating routine ophthalmologic screening. Some children progress to extended disease with a worse prognosis.
Polyarticular JIA involves five or more joints within six months and may resemble adult rheumatoid arthritis, particularly in older girls with positive rheumatoid factor. Joint involvement is often symmetric, affecting both small and large joints, and may include the cervical spine and temporomandibular joint. Systemic symptoms are generally mild, limited to fatigue or anemia.
Psoriatic JIA presents with asymmetric arthritis of large joints, frequently involving the lower extremities or spine, and may be associated with psoriasis, dactylitis, nail pitting, or a family history of psoriasis. Enthesitis-related arthritis primarily affects older boys and involves lower extremity joints and the sacroiliac region, often accompanied by limited spinal motion and uveitis.
History And Physical Examination
The hallmark presentation of JIA is gradual-onset joint stiffness and swelling that is worse in the morning or after periods of inactivity and improves with movement. Children with systemic-onset disease are more likely to present to the emergency department due to acute illness, whereas other subtypes evolve slowly. Rapid onset of severe pain, warmth, and erythema in a joint is atypical for JIA and should prompt evaluation for infection or other inflammatory causes. Physical examination should focus on identifying systemic illness, documenting joint involvement, assessing range of motion, and noting signs of inflammation or functional impairment.
Initial Evaluation And Diagnostic Strategy
The primary objectives in the acute setting are to exclude septic arthritis, malignancy, and other identifiable causes of joint inflammation, as well as complications related to long-term immunosuppressive therapy. Basic laboratory studies include complete blood count and inflammatory markers, with blood cultures added if the child appears ill. Additional testing such as ANA, RF, HLA-B27, and liver enzymes may aid in subtype classification. Imaging with plain radiographs may show early soft tissue swelling and effusion, with later findings including osteoporosis and joint destruction. Ultrasound is helpful for detecting small effusions and guiding arthrocentesis when infection is suspected.
Differential Diagnostic Considerations
The differential diagnosis is broad and includes trauma, septic arthritis, viral or bacterial infections, Lyme disease in endemic regions, rheumatic fever, connective tissue diseases, orthopedic disorders such as Legg–Calvé–Perthes disease, and malignancy. Severe pain out of proportion to exam findings or midshaft bone pain should raise concern for neoplasm.
Management In The Emergency Setting
Emergency care focuses on identifying serious alternative diagnoses and stabilizing ill-appearing children. Toxic-appearing patients require prompt supportive care, including oxygen and intravenous access. For known JIA patients presenting with disease flares, management should be coordinated with the child’s rheumatologist. Antibiotics are reserved for confirmed or strongly suspected joint infection.
Pharmacologic Therapy Principles
Treatment strategies aim to control inflammation, preserve joint function, and support normal growth. Mild forms of JIA may respond to nonsteroidal anti-inflammatory drugs alone, while more severe or systemic disease often necessitates disease-modifying antirheumatic drugs or biologic agents. Early aggressive therapy is now common to reduce long-term complications. NSAIDs remain first-line for many patients, while intra-articular corticosteroid injections can provide prolonged relief in selected joints. Systemic corticosteroids, methotrexate, sulfasalazine, and biologic agents targeting specific cytokines are used based on disease severity and subtype, with careful monitoring for immunosuppression and adverse effects.
Disposition And Long-Term Care
Hospital admission is indicated when diagnosis is uncertain, the child appears systemically ill, or septic arthritis is suspected. Most stable patients without infection may be discharged once pain is controlled and follow-up is assured. Long-term management requires regular rheumatology care, and children—particularly those with pauciarticular disease—must undergo frequent ophthalmologic examinations to detect silent uveitis before irreversible damage occurs.
Key Clinical Insights And Common Pitfalls
Always exclude acute joint infection, particularly in endemic areas for Lyme disease. Prolonged daily fevers with arthritis unresponsive to antibiotics should prompt consideration of systemic-onset JIA. Be vigilant for macrophage activation syndrome in children with systemic disease who appear septic or deteriorate rapidly. A careful review of current medications is essential to identify adverse effects or immunosuppression that may alter presentation and risk.
- Published on
Emergency and Acute Medicine – Degenerative Arthritis (Osteoarthritis)
Overview And Disease Background
Degenerative arthritis, commonly known as osteoarthritis, is the most prevalent progressive joint disorder and a leading cause of chronic musculoskeletal pain in older adults. It primarily affects weight-bearing and frequently used joints and represents a gradual failure of joint cartilage with secondary changes in surrounding bone and soft tissue. Although most cases occur in the elderly, younger patients may be affected following significant joint trauma.
Pathogenesis And Risk Factors
Osteoarthritis develops from cumulative mechanical stress on synovial joints over time, leading to progressive breakdown of articular cartilage. This degeneration triggers reactive bone formation at joint margins and subchondral sclerosis, resulting in reduced joint cushioning and altered biomechanics. Contributing risk factors include advancing age, obesity, prior joint injury, genetic predisposition, sex-related differences, and environmental or occupational joint loading.
Clinical Features And Symptom Pattern
Patients typically report chronic, gradually worsening joint pain that is exacerbated by activity or weight bearing and relieved with rest. Joint involvement is often asymmetric and commonly affects the knees, hips, hands, feet, and spine. Morning stiffness is brief, usually lasting less than 30 minutes, distinguishing osteoarthritis from inflammatory arthritides. As disease progresses, joint deformity and restricted range of motion become evident. Bony enlargements such as Heberden nodes at the distal interphalangeal joints and Bouchard nodes at the proximal interphalangeal joints are characteristic findings. Systemic symptoms are notably absent, and crepitus with movement is common.
Evaluation And Initial Assessment
Assessment begins with a detailed joint examination focusing on pain localization, range of motion, stability, and functional limitation. Plain radiographs are the primary imaging modality and typically demonstrate joint space narrowing, marginal osteophyte formation, subchondral sclerosis, and irregular joint contours. In the presence of joint effusion, synovial fluid analysis may be both diagnostic and therapeutic. Arthrocentesis is mandatory when warmth, erythema, or significant swelling raises concern for septic arthritis or crystalline disease. In such cases, inflammatory markers and blood counts may assist in excluding infection.
Diagnostic Findings
Synovial fluid analysis in osteoarthritis usually reveals clear fluid with mildly elevated leukocyte counts below inflammatory thresholds, a low proportion of polymorphonuclear cells, and glucose levels comparable to serum. Radiographic findings remain the cornerstone of diagnosis and correlate with structural disease, though symptom severity may not always align with imaging changes.
Differential Diagnostic Considerations
Conditions that may mimic or coexist with degenerative arthritis include gout or pseudogout, septic arthritis, rheumatoid arthritis, hemarthrosis, Charcot arthropathy, and periarticular soft tissue disorders such as bursitis or cellulitis. Careful clinical correlation is essential to avoid missed diagnoses.
Management Principles In The Emergency Setting
Treatment is individualized and directed toward symptom relief rather than radiographic severity. Acute management focuses on pain control and preservation of joint function. Temporary immobilization may be appropriate until fracture is excluded, but prolonged immobilization should be avoided. Patients should be encouraged to maintain gentle joint movement and begin strengthening exercises once pain is controlled.
Procedural And Pharmacologic Therapy
Ultrasound-guided arthrocentesis and intra-articular corticosteroid injection can provide effective symptom relief in selected patients, with or without joint effusion. Strict aseptic technique is essential, and corticosteroids must not be administered if septic arthritis cannot be confidently excluded. Medication therapy typically begins with acetaminophen due to its favorable safety profile. Nonsteroidal anti-inflammatory drugs may be added if pain persists, with careful attention to gastrointestinal and cardiovascular risk factors. Adjunctive options such as glucosamine and chondroitin may offer modest benefit in some patients. Lifestyle interventions, particularly weight reduction and muscle strengthening, play a central role in long-term disease control.
Disposition And Follow-Up Planning
Hospital admission is rarely required unless fracture, infection, or severe functional limitation is present. Most patients can be safely discharged once pain is controlled and ambulation is adequate. Follow-up with primary care, sports medicine, or orthopedics is recommended for ongoing management, rehabilitation planning, and consideration of advanced therapies if symptoms progress.
Overview And Disease Background
Degenerative arthritis, commonly known as osteoarthritis, is the most prevalent progressive joint disorder and a leading cause of chronic musculoskeletal pain in older adults. It primarily affects weight-bearing and frequently used joints and represents a gradual failure of joint cartilage with secondary changes in surrounding bone and soft tissue. Although most cases occur in the elderly, younger patients may be affected following significant joint trauma.
Pathogenesis And Risk Factors
Osteoarthritis develops from cumulative mechanical stress on synovial joints over time, leading to progressive breakdown of articular cartilage. This degeneration triggers reactive bone formation at joint margins and subchondral sclerosis, resulting in reduced joint cushioning and altered biomechanics. Contributing risk factors include advancing age, obesity, prior joint injury, genetic predisposition, sex-related differences, and environmental or occupational joint loading.
Clinical Features And Symptom Pattern
Patients typically report chronic, gradually worsening joint pain that is exacerbated by activity or weight bearing and relieved with rest. Joint involvement is often asymmetric and commonly affects the knees, hips, hands, feet, and spine. Morning stiffness is brief, usually lasting less than 30 minutes, distinguishing osteoarthritis from inflammatory arthritides. As disease progresses, joint deformity and restricted range of motion become evident. Bony enlargements such as Heberden nodes at the distal interphalangeal joints and Bouchard nodes at the proximal interphalangeal joints are characteristic findings. Systemic symptoms are notably absent, and crepitus with movement is common.
Evaluation And Initial Assessment
Assessment begins with a detailed joint examination focusing on pain localization, range of motion, stability, and functional limitation. Plain radiographs are the primary imaging modality and typically demonstrate joint space narrowing, marginal osteophyte formation, subchondral sclerosis, and irregular joint contours. In the presence of joint effusion, synovial fluid analysis may be both diagnostic and therapeutic. Arthrocentesis is mandatory when warmth, erythema, or significant swelling raises concern for septic arthritis or crystalline disease. In such cases, inflammatory markers and blood counts may assist in excluding infection.
Diagnostic Findings
Synovial fluid analysis in osteoarthritis usually reveals clear fluid with mildly elevated leukocyte counts below inflammatory thresholds, a low proportion of polymorphonuclear cells, and glucose levels comparable to serum. Radiographic findings remain the cornerstone of diagnosis and correlate with structural disease, though symptom severity may not always align with imaging changes.
Differential Diagnostic Considerations
Conditions that may mimic or coexist with degenerative arthritis include gout or pseudogout, septic arthritis, rheumatoid arthritis, hemarthrosis, Charcot arthropathy, and periarticular soft tissue disorders such as bursitis or cellulitis. Careful clinical correlation is essential to avoid missed diagnoses.
Management Principles In The Emergency Setting
Treatment is individualized and directed toward symptom relief rather than radiographic severity. Acute management focuses on pain control and preservation of joint function. Temporary immobilization may be appropriate until fracture is excluded, but prolonged immobilization should be avoided. Patients should be encouraged to maintain gentle joint movement and begin strengthening exercises once pain is controlled.
Procedural And Pharmacologic Therapy
Ultrasound-guided arthrocentesis and intra-articular corticosteroid injection can provide effective symptom relief in selected patients, with or without joint effusion. Strict aseptic technique is essential, and corticosteroids must not be administered if septic arthritis cannot be confidently excluded. Medication therapy typically begins with acetaminophen due to its favorable safety profile. Nonsteroidal anti-inflammatory drugs may be added if pain persists, with careful attention to gastrointestinal and cardiovascular risk factors. Adjunctive options such as glucosamine and chondroitin may offer modest benefit in some patients. Lifestyle interventions, particularly weight reduction and muscle strengthening, play a central role in long-term disease control.
Disposition And Follow-Up Planning
Hospital admission is rarely required unless fracture, infection, or severe functional limitation is present. Most patients can be safely discharged once pain is controlled and ambulation is adequate. Follow-up with primary care, sports medicine, or orthopedics is recommended for ongoing management, rehabilitation planning, and consideration of advanced therapies if symptoms progress.
- Published on
Emergency and Acute Medicine – Acute Arterial Occlusion
Overview And Core Concepts
Acute arterial occlusion represents a sudden and critical interruption of blood flow to an extremity, placing limb viability at immediate risk. This condition most commonly results from embolic obstruction, in situ thrombosis, arterial dissection, or traumatic vascular injury. Without prompt restoration of perfusion, irreversible ischemic damage typically develops within six hours, leading to functional impairment or limb loss. In patients with chronic arterial disease, preexisting collateral circulation may delay tissue necrosis beyond this window.
Pathophysiology And Mechanisms
Embolic occlusion usually arises from thrombus or atherosclerotic debris originating in the heart or proximal arteries, frequently lodging at sites of abrupt arterial narrowing. Thrombosis often occurs on a background of atherosclerosis, vascular grafts, aneurysms, or hypercoagulable states. Traumatic causes include penetrating or blunt injury resulting in intimal disruption, dissection, transection, or compressive vascular damage. Iatrogenic injury may follow catheterization or endovascular procedures. The resulting ischemia leads to progressive nerve and muscle dysfunction as metabolic waste accumulates and oxygen delivery ceases.
Clinical Presentation
Patients classically present with the abrupt onset of severe limb pain accompanied by coldness and pallor. The hallmark features are described by the “six Ps”: pain, pallor, paresthesias, paralysis, pulselessness, and poikilothermia. Sensory disturbances typically precede motor weakness, beginning distally and progressing proximally. In embolic events, symptoms are sudden and dramatic, whereas thrombotic occlusion may evolve more gradually. Advanced ischemia is suggested by absent capillary refill, skin mottling, cyanosis, and profound neurologic deficits, all of which indicate a poor prognosis. A subset of patients may develop painful blue or violaceous discoloration of the toes, known as blue toe syndrome.
History And Physical Examination
Accurate determination of symptom onset is essential, as ischemic duration strongly predicts outcome. A history of claudication, atrial fibrillation, recent myocardial infarction, valvular disease, vascular interventions, or trauma should be sought. Examination focuses on documenting sensory loss, muscle strength, skin temperature and color, and pulse deficits. Signs of chronic arterial insufficiency, such as hair loss and atrophic skin, may indicate underlying peripheral vascular disease. Measurement of the ankle–brachial index is helpful, with values below 0.5 strongly suggesting acute occlusion.
Diagnostic Strategy
Acute arterial occlusion is primarily a clinical diagnosis, and management decisions should not be delayed for extensive testing. Laboratory studies assess metabolic derangements and muscle injury, including electrolytes, renal function, complete blood count, and creatine phosphokinase. Duplex ultrasonography may assist in localizing arterial obstruction, while CT angiography or MR angiography can provide detailed vascular mapping when time and patient stability permit. Angiography remains useful for definitive classification and planning intervention but is often performed in conjunction with treatment.
Severity Classification
Limbs are categorized as viable, threatened, or nonviable based on neurologic findings, capillary refill, and Doppler signals. Viable limbs have pain without sensory or motor loss and require urgent but not immediate intervention. Threatened limbs show sensory deficits with or without weakness and mandate prompt revascularization. Nonviable limbs exhibit paralysis, profound sensory loss, absent capillary flow, and skin marbling, indicating irreversible ischemia and the need for amputation.
Management In The Emergency Setting
Initial care prioritizes rapid recognition, vascular surgery consultation, and anticoagulation. The affected limb should be kept dependent and protected from temperature extremes; elevation or application of heat or ice is contraindicated. Systemic anticoagulation with intravenous unfractionated heparin should be initiated promptly unless contraindicated. Analgesia and supplemental oxygen are provided as needed. Definitive treatment depends on limb viability and includes surgical embolectomy, thrombolysis, endovascular repair, or bypass. Nonviable limbs require urgent amputation to prevent systemic complications.
Disposition And Follow-Up
All patients with suspected acute arterial occlusion require hospital admission following emergent vascular consultation. Patients with chronic occlusive disease who have stable symptoms and preserved perfusion may be discharged with close outpatient vascular follow-up, provided no acute precipitating factors are identified and clear return precautions are given.
Clinical Insights And Common Pitfalls
Acute arterial occlusion is a limb-threatening emergency in which time to reperfusion is critical. Absence of pain does not exclude severe ischemia, as sensory loss may reflect advanced nerve injury. Normal skin color early in the course can be misleading, and pulselessness is often a late finding. Limb elevation or thermal manipulation can worsen ischemia and should be avoided. Early anticoagulation and rapid surgical involvement are essential to maximize limb salvage and patient outcomes.
Overview And Core Concepts
Acute arterial occlusion represents a sudden and critical interruption of blood flow to an extremity, placing limb viability at immediate risk. This condition most commonly results from embolic obstruction, in situ thrombosis, arterial dissection, or traumatic vascular injury. Without prompt restoration of perfusion, irreversible ischemic damage typically develops within six hours, leading to functional impairment or limb loss. In patients with chronic arterial disease, preexisting collateral circulation may delay tissue necrosis beyond this window.
Pathophysiology And Mechanisms
Embolic occlusion usually arises from thrombus or atherosclerotic debris originating in the heart or proximal arteries, frequently lodging at sites of abrupt arterial narrowing. Thrombosis often occurs on a background of atherosclerosis, vascular grafts, aneurysms, or hypercoagulable states. Traumatic causes include penetrating or blunt injury resulting in intimal disruption, dissection, transection, or compressive vascular damage. Iatrogenic injury may follow catheterization or endovascular procedures. The resulting ischemia leads to progressive nerve and muscle dysfunction as metabolic waste accumulates and oxygen delivery ceases.
Clinical Presentation
Patients classically present with the abrupt onset of severe limb pain accompanied by coldness and pallor. The hallmark features are described by the “six Ps”: pain, pallor, paresthesias, paralysis, pulselessness, and poikilothermia. Sensory disturbances typically precede motor weakness, beginning distally and progressing proximally. In embolic events, symptoms are sudden and dramatic, whereas thrombotic occlusion may evolve more gradually. Advanced ischemia is suggested by absent capillary refill, skin mottling, cyanosis, and profound neurologic deficits, all of which indicate a poor prognosis. A subset of patients may develop painful blue or violaceous discoloration of the toes, known as blue toe syndrome.
History And Physical Examination
Accurate determination of symptom onset is essential, as ischemic duration strongly predicts outcome. A history of claudication, atrial fibrillation, recent myocardial infarction, valvular disease, vascular interventions, or trauma should be sought. Examination focuses on documenting sensory loss, muscle strength, skin temperature and color, and pulse deficits. Signs of chronic arterial insufficiency, such as hair loss and atrophic skin, may indicate underlying peripheral vascular disease. Measurement of the ankle–brachial index is helpful, with values below 0.5 strongly suggesting acute occlusion.
Diagnostic Strategy
Acute arterial occlusion is primarily a clinical diagnosis, and management decisions should not be delayed for extensive testing. Laboratory studies assess metabolic derangements and muscle injury, including electrolytes, renal function, complete blood count, and creatine phosphokinase. Duplex ultrasonography may assist in localizing arterial obstruction, while CT angiography or MR angiography can provide detailed vascular mapping when time and patient stability permit. Angiography remains useful for definitive classification and planning intervention but is often performed in conjunction with treatment.
Severity Classification
Limbs are categorized as viable, threatened, or nonviable based on neurologic findings, capillary refill, and Doppler signals. Viable limbs have pain without sensory or motor loss and require urgent but not immediate intervention. Threatened limbs show sensory deficits with or without weakness and mandate prompt revascularization. Nonviable limbs exhibit paralysis, profound sensory loss, absent capillary flow, and skin marbling, indicating irreversible ischemia and the need for amputation.
Management In The Emergency Setting
Initial care prioritizes rapid recognition, vascular surgery consultation, and anticoagulation. The affected limb should be kept dependent and protected from temperature extremes; elevation or application of heat or ice is contraindicated. Systemic anticoagulation with intravenous unfractionated heparin should be initiated promptly unless contraindicated. Analgesia and supplemental oxygen are provided as needed. Definitive treatment depends on limb viability and includes surgical embolectomy, thrombolysis, endovascular repair, or bypass. Nonviable limbs require urgent amputation to prevent systemic complications.
Disposition And Follow-Up
All patients with suspected acute arterial occlusion require hospital admission following emergent vascular consultation. Patients with chronic occlusive disease who have stable symptoms and preserved perfusion may be discharged with close outpatient vascular follow-up, provided no acute precipitating factors are identified and clear return precautions are given.
Clinical Insights And Common Pitfalls
Acute arterial occlusion is a limb-threatening emergency in which time to reperfusion is critical. Absence of pain does not exclude severe ischemia, as sensory loss may reflect advanced nerve injury. Normal skin color early in the course can be misleading, and pulselessness is often a late finding. Limb elevation or thermal manipulation can worsen ischemia and should be avoided. Early anticoagulation and rapid surgical involvement are essential to maximize limb salvage and patient outcomes.
- Published on
Emergency and Acute Medicine – Arterial Gas Embolism
Overview And Pathophysiology
Arterial gas embolism occurs when air enters the pulmonary venous circulation, most commonly after alveolar rupture, and is then distributed through the systemic arterial system. Clinical effects depend on where gas bubbles lodge, particularly within cerebral, coronary, or other end-organ circulations. This condition is also referred to as dysbaric air embolism or cerebral air embolism. It typically results from lung overpressurization, where trapped intrapulmonary air expands during ascent, tears alveoli, and gains access to the vasculature. The underlying mechanism follows Boyle’s law, in which gas volume increases as ambient pressure decreases during ascent.
Causes And Risk Factors
The most common cause is breath-holding during ascent from a compressed-air dive, leading to rapid lung overexpansion and widespread arterial bubble dissemination. Arterial gas embolism may also occur through pulmonary arteriovenous shunts or paradoxical embolization via a patent foramen ovale. Nondiving causes include iatrogenic introduction of air during central venous catheter placement, cardiothoracic surgery, or hemodialysis, as well as penetrating cardiac trauma requiring emergent repair.
Clinical Presentation
Symptoms usually begin abruptly, with nearly all dive-related cases presenting within the first 5–10 minutes after surfacing, often within the first 2 minutes. Neurologic involvement predominates and may resemble an acute stroke, ranging from confusion and focal deficits to seizures, coma, or cardiopulmonary arrest. Transient improvement may occur as bubbles redistribute, but relapse is common and should not reassure clinicians. Pulmonary findings include dyspnea, pleuritic chest pain, hemoptysis, and subcutaneous emphysema. Cardiac involvement may manifest as myocardial ischemia, reduced cardiac output from intracardiac air, or a characteristic precordial crunch known as Hamman sign. Renal infarction and other end-organ ischemia may also occur.
History And Examination
A focused history should establish the timing of symptom onset relative to dive ascent or procedural intervention, as rapid onset strongly supports the diagnosis. Inquiry into breath-holding, panic, equipment malfunction, or unusual ascent conditions is essential. Physical examination must emphasize a detailed neurologic assessment, documenting motor, sensory, cerebellar, and cranial nerve findings, as presentations are highly variable.
Diagnostic Approach
Arterial gas embolism is primarily a clinical diagnosis based on exposure history and abrupt symptom onset. Laboratory studies may show elevated creatine kinase as a marker of cerebral injury, along with routine assessment of electrolytes, renal function, and arterial blood gases when respiratory compromise is present. Imaging may reveal pneumothorax or mediastinal emphysema on chest radiography, while chest CT can identify lung injury or hemorrhage. Neuroimaging may demonstrate cerebral air but should never delay definitive therapy. Echocardiography may identify a patent foramen ovale. When suspicion is high, treatment should proceed without waiting for confirmatory imaging.
Differential Considerations
Key alternatives include ischemic stroke unrelated to diving and neurologic manifestations of decompression sickness. Timing of onset, rapid progression, and association with ascent strongly favor arterial gas embolism.
Initial Stabilization And Emergency Care
Immediate management focuses on airway, breathing, and circulation. High-flow 100% oxygen should be administered via a tight-fitting mask to reduce bubble size and improve tissue oxygenation. Early intubation is indicated for airway protection or respiratory failure. Intravenous access and volume resuscitation should be established promptly. Patients should be handled carefully, as neurologic status may fluctuate.
Definitive Management
Hyperbaric oxygen therapy is the cornerstone of treatment for all cases of arterial gas embolism and should be initiated as soon as possible. Early coordination with the nearest hyperbaric facility is critical, with transport in aircraft capable of maintaining low cabin altitude when required. A prophylactic chest tube may be placed in patients with pneumothorax to prevent deterioration during recompression. Endotracheal tube and Foley catheter balloons should be filled with saline or water rather than air to avoid expansion-related injury. Consultation with specialized dive medicine services is strongly recommended.
Disposition And Follow-Up
All patients require hospital admission following initial hyperbaric therapy for observation and repeat neurologic evaluation. Discharge directly from the emergency department is not appropriate for any patient with suspected or confirmed arterial gas embolism. Ongoing hyperbaric follow-up is required based on clinical response.
Clinical Cautions And Diagnostic Pitfalls
Arterial gas embolism should be suspected when neurologic symptoms develop during ascent or within minutes of surfacing, or after procedures with risk of intravascular air. Apparent rapid neurologic recovery is unreliable and does not exclude severe injury, as symptom recurrence is common. Definitive treatment should never be delayed for imaging when clinical suspicion is high. During recompression, all air-filled device balloons must be replaced with fluid to prevent expansion-related complications.
Overview And Pathophysiology
Arterial gas embolism occurs when air enters the pulmonary venous circulation, most commonly after alveolar rupture, and is then distributed through the systemic arterial system. Clinical effects depend on where gas bubbles lodge, particularly within cerebral, coronary, or other end-organ circulations. This condition is also referred to as dysbaric air embolism or cerebral air embolism. It typically results from lung overpressurization, where trapped intrapulmonary air expands during ascent, tears alveoli, and gains access to the vasculature. The underlying mechanism follows Boyle’s law, in which gas volume increases as ambient pressure decreases during ascent.
Causes And Risk Factors
The most common cause is breath-holding during ascent from a compressed-air dive, leading to rapid lung overexpansion and widespread arterial bubble dissemination. Arterial gas embolism may also occur through pulmonary arteriovenous shunts or paradoxical embolization via a patent foramen ovale. Nondiving causes include iatrogenic introduction of air during central venous catheter placement, cardiothoracic surgery, or hemodialysis, as well as penetrating cardiac trauma requiring emergent repair.
Clinical Presentation
Symptoms usually begin abruptly, with nearly all dive-related cases presenting within the first 5–10 minutes after surfacing, often within the first 2 minutes. Neurologic involvement predominates and may resemble an acute stroke, ranging from confusion and focal deficits to seizures, coma, or cardiopulmonary arrest. Transient improvement may occur as bubbles redistribute, but relapse is common and should not reassure clinicians. Pulmonary findings include dyspnea, pleuritic chest pain, hemoptysis, and subcutaneous emphysema. Cardiac involvement may manifest as myocardial ischemia, reduced cardiac output from intracardiac air, or a characteristic precordial crunch known as Hamman sign. Renal infarction and other end-organ ischemia may also occur.
History And Examination
A focused history should establish the timing of symptom onset relative to dive ascent or procedural intervention, as rapid onset strongly supports the diagnosis. Inquiry into breath-holding, panic, equipment malfunction, or unusual ascent conditions is essential. Physical examination must emphasize a detailed neurologic assessment, documenting motor, sensory, cerebellar, and cranial nerve findings, as presentations are highly variable.
Diagnostic Approach
Arterial gas embolism is primarily a clinical diagnosis based on exposure history and abrupt symptom onset. Laboratory studies may show elevated creatine kinase as a marker of cerebral injury, along with routine assessment of electrolytes, renal function, and arterial blood gases when respiratory compromise is present. Imaging may reveal pneumothorax or mediastinal emphysema on chest radiography, while chest CT can identify lung injury or hemorrhage. Neuroimaging may demonstrate cerebral air but should never delay definitive therapy. Echocardiography may identify a patent foramen ovale. When suspicion is high, treatment should proceed without waiting for confirmatory imaging.
Differential Considerations
Key alternatives include ischemic stroke unrelated to diving and neurologic manifestations of decompression sickness. Timing of onset, rapid progression, and association with ascent strongly favor arterial gas embolism.
Initial Stabilization And Emergency Care
Immediate management focuses on airway, breathing, and circulation. High-flow 100% oxygen should be administered via a tight-fitting mask to reduce bubble size and improve tissue oxygenation. Early intubation is indicated for airway protection or respiratory failure. Intravenous access and volume resuscitation should be established promptly. Patients should be handled carefully, as neurologic status may fluctuate.
Definitive Management
Hyperbaric oxygen therapy is the cornerstone of treatment for all cases of arterial gas embolism and should be initiated as soon as possible. Early coordination with the nearest hyperbaric facility is critical, with transport in aircraft capable of maintaining low cabin altitude when required. A prophylactic chest tube may be placed in patients with pneumothorax to prevent deterioration during recompression. Endotracheal tube and Foley catheter balloons should be filled with saline or water rather than air to avoid expansion-related injury. Consultation with specialized dive medicine services is strongly recommended.
Disposition And Follow-Up
All patients require hospital admission following initial hyperbaric therapy for observation and repeat neurologic evaluation. Discharge directly from the emergency department is not appropriate for any patient with suspected or confirmed arterial gas embolism. Ongoing hyperbaric follow-up is required based on clinical response.
Clinical Cautions And Diagnostic Pitfalls
Arterial gas embolism should be suspected when neurologic symptoms develop during ascent or within minutes of surfacing, or after procedures with risk of intravascular air. Apparent rapid neurologic recovery is unreliable and does not exclude severe injury, as symptom recurrence is common. Definitive treatment should never be delayed for imaging when clinical suspicion is high. During recompression, all air-filled device balloons must be replaced with fluid to prevent expansion-related complications.
